bis(trichloromethyl)sulfone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 62478 |
CHEMBL ID | 3561446 |
SCHEMBL ID | 21383 |
MeSH ID | M0148880 |
Synonym |
---|
trichloromethylsulfone |
nsc21713 |
bis(trichloromethyl) sulfone |
sulfone, bis(trichloromethyl) |
nsc-21713 |
chlorosulfona |
hexachlorodimethyl sulfone |
3064-70-8 |
clorosulfona |
methane, sulfonylbis[trichloro- |
n 1386 |
methane, sulfonylbis(trichloro- |
n-1386 biocide |
caswell no. 104 |
slimicide e |
hsdb 7126 |
bis(trichloromethyl)sulfone |
ccris 809 |
nsc 21713 |
epa pesticide chemical code 035601 |
bis(trichloromethyl) sulphone |
einecs 221-310-4 |
brn 1783352 |
trichloro(trichloromethylsulfonyl)methane |
FT-0669131 |
4-03-00-00285 (beilstein handbook reference) |
ptz0qe9824 , |
methane, 1,1'-sulfonylbis(1,1,1-trichloro- |
unii-ptz0qe9824 |
bis(trichloromethyl)sulphone |
bis(trichloromethyl)sulfone [hsdb] |
SCHEMBL21383 |
dtxcid1012331 |
tox21_303827 |
cas-3064-70-8 |
NCGC00357286-01 |
dtxsid3032331 , |
CHEMBL3561446 |
trichloromethyl sulfone, aldrichcpr |
bis-(trichloromethyl)sulfone |
methane, 1,1'-sulfonylbis[1,1,1-trichloro- |
Q27286750 |
Excerpt | Reference | Relevance |
---|---|---|
"The oral LD50 for bis(trichloromethyl) sulfone (N-1386 Biocide) in male rats was 691 mg/kg." | ( Anticholinesterase effect and toxicity of bis(trichloromethyl) sulfone (N-1386 Biocide) in rats. Castles, TR; Sprague, GL, 1987) | 0.27 |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 20.0048 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 37.7116 | 3.1890 | 29.8841 | 59.4836 | AID1224846; AID1224894 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 9.5482 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521; AID1159523 |
SMAD family member 2 | Homo sapiens (human) | Potency | 48.9662 | 0.1737 | 34.3047 | 61.8120 | AID1346924 |
SMAD family member 3 | Homo sapiens (human) | Potency | 48.9662 | 0.1737 | 34.3047 | 61.8120 | AID1346924 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 2.8033 | 0.0007 | 14.5928 | 83.7951 | AID1259369; AID1259392 |
AR protein | Homo sapiens (human) | Potency | 18.6582 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243; AID1259247 |
estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 39.5978 | 0.0006 | 57.9133 | 22,387.1992 | AID1259377; AID1259378 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 33.1500 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224839; AID1224893 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 10.7132 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 34.7027 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 62.9310 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 27.3060 | 0.0002 | 29.3054 | 16,493.5996 | AID1259244; AID1259248 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 61.1306 | 0.0016 | 28.0151 | 77.1139 | AID1259385; AID1259395 |
thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 33.8260 | 0.1549 | 17.8702 | 43.6557 | AID1346877 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 54.9410 | 0.0578 | 21.1097 | 61.2679 | AID1159526 |
Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 27.3060 | 0.0015 | 57.7890 | 15,848.9004 | AID1259244 |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 27.3060 | 0.0015 | 51.7393 | 15,848.9004 | AID1259244 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
plasma membrane | Glutamate receptor 2 | Rattus norvegicus (Norway rat) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.27) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |